File:Atezolizumab for treatment of non small cell lung cancer in the first line, IMpower 110, 130 and 150 studies.jpg

Original file(492 × 935 pixels, file size: 139 KB, MIME type: image/jpeg)

Summary

Description
English: Patients median survival with Atezolizumab (Atezo) for treatment of non small cell lung cancer in the first line, IMpower 110 comparing Atezo to chemotherapy , IMpower 130 comparing Atezo+chemotherapy to chemotherapy and IMpower150 comparing ATEZOLIZUMAB+ chemotherapy + bevacizumab versus chemotherapy + bevacizumab
Date
Source Adapted from: First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373.https://doi.org/10.3390/ph13110373
Author Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya

Licensing

w:en:Creative Commons
attribution share alike
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.

Captions

Patients median survival with Atezolizumab for treatment of non small cell lung cancer in the first line, IMpower 110, 130 and 150 studies https://doi.org/10.3390/ph13110373

Items portrayed in this file

depicts

5 November 2020

image/jpeg

b18e5c98d9f2a5539760b9daa9e5296ef2e8649c

141,874 byte

935 pixel

492 pixel

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current03:05, 27 January 2021Thumbnail for version as of 03:05, 27 January 2021492 × 935 (139 KB)SannecolaUploaded a work by Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya from Adapted from: First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373.https://doi.org/10.3390/ph13110373 with UploadWizard
The following pages on the English Wikipedia use this file (pages on other projects are not listed):

Global file usage

Metadata